← Back to Search

Advance Care Planning for Cancer

N/A

Waitlist Available

Led By Neil S Wenger, MD

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months

Awards & highlights

Study Summary

This trial will be testing three different ways to help people plan for their healthcare, by either providing them with information, prompting them to use a website, or engaging with them directly. They will be measuring how well these different approaches work in terms of getting people to complete an advance directive (a legal document that outlines someone's healthcare wishes), and whether people receive the care they want in accordance with their directive.

Who is the study for?

This trial is for seriously ill patients who speak English or Spanish, have visited a primary care clinic at least twice in the past year, and can give informed consent. It's aimed at those with advanced cancer, heart failure, COPD, liver disease, kidney disease, ALS or are vulnerable elders with serious illness.Check my eligibility

What is being tested?

The study tests three advance care planning approaches in primary clinics: (1) receiving an advance directive with targeted messaging; (2) that plus prompts to use 'Prepare For Your Care' online; (3) both previous interventions plus help from a clinic facilitator.See study design

What are the potential side effects?

Since this trial involves non-medical interventions like planning tools and facilitation rather than drugs or medical procedures, traditional side effects are not applicable. However, emotional or psychological distress could potentially be experienced.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Advance directive completion, 12 months

Research cohort: Goal concordant care, cross-sectional survey, 12 months

Secondary outcome measures

Advance directive completion, 24 months

New advance directive completion, 12 months

New advance directive completion, 24 months

+4 more

Other outcome measures

Healthcare utilization among decedents

Research cohort: advance care planning process, 12 months

Research cohort: advance care planning process, 24 months

Trial Design

3Treatment groups

Active Control

Group I: Advance directive, Prepare and FacilitatorActive Control3 Interventions

Messaging and advance directive distribution, introduction to the Prepare For Your Care website, plus patient engagement from a trained facilitator who also can interact with the primary care physician. All arms receive physician advance care planning education at the clinic level.

Group II: Advance directiveActive Control1 Intervention

Messaging and advance directive distribution. All arms receive physician advance care planning education at the clinic level.

Group III: Advance directive and PrepareActive Control2 Interventions

Messaging and advance directive distribution plus introduction to the Prepare For Your Care website. All arms receive physician advance care planning education at the clinic level.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, IrvineOTHER

545 Previous Clinical Trials

1,916,711 Total Patients Enrolled

University of California, Los AngelesLead Sponsor

1,537 Previous Clinical Trials

10,261,100 Total Patients Enrolled

University of California, San FranciscoOTHER

2,515 Previous Clinical Trials

15,238,067 Total Patients Enrolled

Media Library

Advance directive Clinical Trial Eligibility Overview. Trial Name: NCT04012749 — N/A

Advance Directives Research Study Groups: Advance directive, Prepare and Facilitator, Advance directive, Advance directive and Prepare

Advance Directives Clinical Trial 2023: Advance directive Highlights & Side Effects. Trial Name: NCT04012749 — N/A

Advance directive 2023 Treatment Timeline for Medical Study. Trial Name: NCT04012749 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the primary goal of this clinical investigation?

"With the main aim of advancing directive completion within 12 months or death, this clinical trial will evaluate secondary objectives such as goal concordant care, cross-sectional survey over 24 months and new advance directive completion at 12 months. In order to account for patient clustering amongst clinics and other factors like age, gender, race/ethnicity etc., logistic regression models will be utilized in an 'as treated' analysis. Finally, a modified Bereaved Family Survey will measure caregiver reports on end of life care quality among decedents."

Answered by AI

Is this trial actively seeking participants at this time?

"Clinicaltrials.gov does not list this particular trial as seeking participants at the moment, given that it was last updated on September 29th 2021 and originally posted two years prior. Fortunately, 166 other trials are still looking for volunteers to join their studies."

Answered by AI